Researchers Use Yeast To Study Batten Disease
Posted on: Monday, 22 December 2008, 09:49 CST
Scientists express human gene mutations in yeast in order to study Batten disease, a fatal childhood neurodegenerative disorder
Scientists report that human gene mutations expressed in yeast cells can predict the severity of Batten Disease, a fatal nervous system disorder that begins during childhood. The new study published in Disease Models & Mechanisms (DMM), describes how the extent of changes in mutated cells paralleled the severity of symptoms seen in humans.
The initial, milder symptoms of Batten disease appear in children between ages 4 and 7. Children with this disorder (also known as juvenile neuronal ceroid lipfuscinosis, or JNCL) suffer vision loss and exhibit learning difficulties and behavioral changes. This is eventually followed by the appearance of seizures, and a devastating, progressive loss of mental and physical function, eventually leading to death before young adulthood.
Mutations in the gene CLN3 cause Batten Disease, but scientists do not fully understand the role of CLN3 in cell function. Thus, in order to learn more about this gene, researchers at the University College London created a variety of mutations based on CLN3 gene defects identified in Batten disease patients. They studied the effects of these mutations in a fission yeast protein highly similar to CLN3. The research team found that human mutations that caused a severe Batten disease progression likewise caused severe cell abnormalities in the yeast. Likewise, mutations found in mild cases of Batten disease resulted in less severe yeast cell changes.
Not only does this study help researchers understand the mechanism underlying Batten disease, but this yeast model can also be used to investigate therapeutic compounds to treat Batten disease and related illnesses.
The report was written by R.L. Haines, S. Codin, and S.E. Mole at the MRC Laboratory for Molecular Cell Biology at University College London. The report is published in the January/February issue of a new research journal, Disease Models & Mechanisms (DMM), published by The Company of Biologists, a non-profit based in Cambridge, UK.
---
On the Net:
Related Articles
- Caltech Researchers Show Efficacy Of Gene Therapy In Mouse Models Of Huntington's Disease
- Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
- Mutated Zebrafish Gene Sheds Light On Human Blindness
- Technique for Creating Authentic Rat Embryonic Stem Cells Published in Cell
- BioReliance Corporation Announces That Sarah Sheridan, Ph.D. Will Deliver a Poster Presentation at the 16th Annual European Society of Gene and Cell Therapy Conference
- IEEE Expresses Interest in Collaborating With International Consortium to Develop Open Access Publishing Model for High-Energy Physics Literature
- Mutated Gene Provides Animal Autism Model
- Mutation Affects Healthy Immune Cells
- Biologists describe key role of signal-transcribing gene during cell cycle
- Apolipoprotein C-III, N-3 Polyunsaturated Fatty Acids, and "Insulin- Resistant" T-455C APOC3 Gene Polymorphism in Heart Disease Patients: Example of Gene-Diet Interaction
 |
 |
User Comments (0)
RSS Feeds